Skip to main content
ImmunityBio, Inc. (IBRX)
NASDAQ: IBRX · Real-Time Price · USD
6.96
-0.33 (-4.53%)
At close: Apr 28, 2026, 4:00 PM EDT
6.99
+0.03 (0.43%)
After-hours: Apr 28, 2026, 7:45 PM EDT

ImmunityBio Employees

As of December 31, 2025, ImmunityBio had 691 total employees, including 684 full-time and 7 part-time employees. The number of employees increased by 11 or 1.62% compared to the previous year.

Employees
691
Change (1Y)
11
Growth (1Y)
1.62%
Revenue / Employee
$163,948
Profits / Employee
-$508,535
Market Cap
7.19B

Employees Chart

Employees History

Date Employees Change Growth
Dec 31, 2025691111.62%
Dec 31, 2024680528.28%
Dec 31, 2023628-97-13.38%
Dec 31, 202272513823.51%
Dec 31, 2021587322121.51%
Dec 31, 2019 Pro Pro Pro

Related Stocks

Company Name Employees
Bio-Techne 3,100
Cytokinetics 673
Vaxcyte 507
Halozyme Therapeutics 423
Krystal Biotech 295
Apogee Therapeutics 261
Kymera Therapeutics 238
Nuvalent 228
Employee Rankings

IBRX News

More News